首页> 美国卫生研究院文献>JIMD Reports >Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2TG Mutation in Wolman Disease
【2h】

Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2TG Mutation in Wolman Disease

机译:溶酶体酸性脂肪酶缺乏症在23例西班牙患者中:沃尔曼病中新型c.966 + 2T G突变的发生率很高

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lysosomal acid lipase (LAL) is a lysosomal key enzyme involved in the intracellular hydrolysis of cholesteryl esters and triglycerides. Patients with very low residual LAL activity present with the infantile severe form Wolman disease (WD), while patients with some residual activity develop the less severe disorder known as Cholesteryl ester storage disorder (CESD). We present the clinical, biochemical, and molecular findings of 23 Spanish patients (22 families) with LAL deficiency. We identified eight different mutations, four of them not previously reported. The novel c.966+2T>G mutation accounted for 75% of the Wolman disease alleles, and the frequent CESD associated c.894G>A mutation accounted for 55% of the CESD alleles in our cohort. Haplotype analysis showed that both mutations co-segregated with a unique haplotype suggesting a common ancestor. Our study contributes to the LAL deficiency acknowledgement with novel mutations and with high frequencies of some unknown mutations for WD.
机译:溶酶体酸性脂肪酶(LAL)是一种溶酶体关键酶,参与胆固醇酯和甘油三酸酯的细胞内水解。残留LAL活性非常低的患者会出现婴儿重症沃尔曼病(WD),而残留活性却有些的患者会发展出较不严重的疾病,即胆固醇酯存储障碍(CESD)。我们介绍了23名LAL缺乏症的西班牙患者(22个家庭)的临床,生化和分子发现。我们确定了八个不同的突变,其中四个以前没有报道过。在我们的队列研究中,新颖的c.966 + 2T> G突变占Wolman疾病等位基因的75%,而频繁的CESD相关c.894G> A突变占CESD等位基因的55%。单倍型分析表明,这两个突变与一个独特的单倍型共同分离,表明一个共同的祖先。我们的研究有助于LAL缺乏认识与新的突变和WD某些未知突变的高频率。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号